On August 17, 2026, a clinical trial listing for PF-08653944 was updated to show a status of completed. The study, registered as NCT07400679, is titled "A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity." It is a Phase 1 trial. The listed purpose of the study is to learn how PF-08653944 is taken up into the blood in adults with overweight or obesity. No results, efficacy data, or safety findings are included in this update. The record reflects only a change in trial status to completed as of the date given. Calcitonin itself remains an approved compound. This trial update pertains specifically to PF-08653944 and does not describe outcomes or conclusions about calcitonin broadly. Readers interested in additional detail can consult the official trial registry entry for further specifics on design and enrollment criteria. For more background, see the compound overview page.</body_markdown>
<parameter name="sources">["https://clinicaltrials.gov/study/NCT07400679"]